Endometrial Adenocarcinoma — Trials

Endometrial Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 18
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06213571	Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas	completed	N/A	80	Mayo ClinicOTHER	1	Jun 22, 2026	clinicaltrials
NCT03460483	Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care(OPTEC)	completed	N/A	1,001	Ohio State University Comprehensive Cancer CenterOTHER	1	Oct 3, 2025